 STONY BROOK, N.Y.-- BUSINESS WIRE --Applied DNA Sciences, Inc. NASDAQ: APDN the Company, a leader in PCR-based DNA technologies, today announced that it plans to release its fiscal 2022 fourth quarter and year-end financial results after the market close on Wednesday, December 14, 2022. 